Oct 07 2026 11:45 PM EST

Oct 07 2026 08:00 AM EST

Acquisition Deals and Sector Tailwinds Lift Some Stocks While Litigation and Spin‑Off Risks Drag Others

RXO (NYSE:RXO) surged more than 20% after C.H. Robinson announced a $5.8 billion acquisition, while Option Care Health (NASDAQ:OPCH) jumped roughly 33% on a $5.8 billion buyout by McKesson and CD&R. Trillium Therapeutics (NASDAQ:TRIL) added about 30% on an analyst upgrade. In contrast, Corteva (NYSE:CTVA) fell over 80% following a $455 million PFAS settlement and a pending spin‑off, and Liquidia (NASDAQ:LQDA) dropped more than 50% after a Delaware court ruled its YUTREPIA product infringed a United Therapeutics patent.